EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit
NEW YORK, Nov. 18, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Edwards Lifesciences Corporation (NYSE: EW) between February 6,